Literature DB >> 11489975

Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb.

J M Revest1, R K Suniara, K Kerr, J J Owen, C Dickson.   

Abstract

Mice deficient for fibroblast growth factor (Fgf)R2-IIIb show a block in thymic growth after embryonic day 12.5, a stage that just precedes its detection in thymic epithelial cells. Fgf7 and Fgf10, the main ligands for FgfR2-IIIb, are expressed in the mesenchyme surrounding the thymic epithelial primordium, and Fgf10-deficient mice also exhibit impaired thymic growth. Hence, Fgf signaling is essential for thymic epithelial proliferation. In addition to the proliferative block, most thymic epithelial cells fail to progress from an immature cytokeratin 5-positive to a cytokeratin 5-negative phenotype. Nevertheless, sufficient epithelial cell differentiation occurs in the severely hypoplastic thymus to allow the development of CD4/CD8-double-positive thymocytes and a very small number of single-positive thymocytes expressing TCRs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489975     DOI: 10.4049/jimmunol.167.4.1954

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

Review 1.  A crucial role for fibroblast growth factor signaling in embryonic mammary gland development.

Authors:  Christian Dillon; Bradley Spencer-Dene; Clive Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

2.  EphB-ephrin-B2 interactions are required for thymus migration during organogenesis.

Authors:  Katie E Foster; Julie Gordon; Kim Cardenas; Henrique Veiga-Fernandes; Taija Makinen; Elena Grigorieva; David G Wilkinson; C Clare Blackburn; Ellen Richie; Nancy R Manley; Ralf H Adams; Dimitris Kioussis; Mark C Coles
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-08       Impact factor: 11.205

Review 3.  Immune-based therapies: an adjunct to antiretroviral treatment.

Authors:  Jeffrey M Jacobson
Journal:  Curr HIV/AIDS Rep       Date:  2005-06       Impact factor: 5.071

Review 4.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

Review 5.  Thymic rejuvenation and aging.

Authors:  Melissa S Ventevogel; Gregory D Sempowski
Journal:  Curr Opin Immunol       Date:  2013-07-04       Impact factor: 7.486

Review 6.  Thymus involution and regeneration: two sides of the same coin?

Authors:  Thomas Boehm; Jeremy B Swann
Journal:  Nat Rev Immunol       Date:  2013-09-20       Impact factor: 53.106

7.  Graded hedgehog and fibroblast growth factor signaling independently regulate pituitary cell fates and help establish the pars distalis and pars intermedia of the zebrafish adenohypophysis.

Authors:  Burcu Guner; A Tuba Ozacar; Jeanne E Thomas; Rolf O Karlstrom
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

8.  Alterations in the thymocyte phenotype of EphB-deficient mice largely affect the double negative cell compartment.

Authors:  David Alfaro; Juan José Muñoz; Javier García-Ceca; Teresa Cejalvo; Eva Jiménez; Agustín Zapata
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

9.  A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.

Authors:  Jeffrey M Jacobson; Hongying Wang; Rebeka Bordi; Lu Zheng; Barry H Gross; Alan L Landay; John Spritzler; Jean-Pierre Routy; Constance Benson; Judith Aberg; Pablo Tebas; David W Haas; Jennifer Tiu; Kristine Coughlin; Lynette Purdue; Rafick-Pierre Sekaly
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

10.  Engineering the human thymic microenvironment to support thymopoiesis in vivo.

Authors:  Brile Chung; Amélie Montel-Hagen; Shundi Ge; Garrett Blumberg; Kenneth Kim; Sam Klein; Yuhua Zhu; Chintan Parekh; Arumugam Balamurugan; Otto O Yang; Gay M Crooks
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.